John Theurer Cancer Center, Hackensack University Medical Center | oneAMYLOIDOSISvoice
×
Or register here
Global Search

Trusted Resources: People & Places

Healthcare providers, researchers, and advocates

Back to Places / Academic & Health Care Centers
John Theurer Cancer Center, Hackensack University Medical Center

John Theurer Cancer Center, Hackensack University Medical Center

92 2nd Street
Hackensack, New Jersey, United States
Phone   Web  
John Theurer Cancer Center at Hackensack University Medical Center is New Jersey’s largest and most comprehensive cancer program. More people in the New Jersey/New York metropolitan area turn to John Theurer Cancer Center for cancer care each year than to any other facility in New Jersey for comprehensive bone marrow and stem cell transplant program, expertise in the management of hematologic malignancies in adults and children, robust clinical trial portfolio etc.
 
The treatment of multiple myeloma is highly personalized at John Theurer Cancer Center, part of Hackensack University Medical Center in New Jersey. Some people have diseases that have the potential to turn into multiple myeloma. These “precursor” disorders include smoldering multiple myeloma and monoclonal gammopathy of undetermined significance (MGUS). If you were diagnosed with one of these disorders, you may have been surprised because they don’t cause any symptoms. Our doctors take a conservative approach to treating patients with smoldering multiple myeloma and MGUS. We’ll monitor you and let you know if or when you may benefit from treatment. 
 
John Theurer Cancer Center is one of the few sites offering chimeric antigen receptor (CAR) T-cell therapy, a highly promising form of personalized immunotherapy for certain blood cancers and has been involved in CAR T-cell research for nearly a decade.

Related Content

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close

Community Key Collaborator

Support for this landing page is provided by an independent education grant from

Translation of this platform made possible through an independent education grant from

© 2024 rareLife solutions Inc.

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close